Moderna to join Nasdaq 100, replacing Warner Bros Discovery
Moderna (MRNA) will join the Nasdaq 100 on October 9, replacing Warner Bros Discovery (WBD). Moderna's stock has risen over sixfold this year, reaching a market cap of approximately $75 billion. Warner Bros Discovery will also be removed from several other major indexes due to its upcoming merger with Paramount Skydance.
How this was made
The 30-second read
Why it matters
The changes affect passive fund allocations and may trigger short‑term price moves in both stocks.
Market read
Index composition changes are a known driver of short‑term price action for the affected constituents.
What to watch
Potential dilution from the upcoming merger could offset index‑related buying for Warner Bros Discovery.
Background
Nasdaq announced a quarterly rebalancing, adding Moderna and removing Warner Bros Discovery as part of routine index maintenance.
Ticker impact
Moderna will be added to the Nasdaq-100 on Oct 9, reflecting its sixfold rally and $75bn market cap.
upward pressure as passive funds add shares
Index additions trigger automatic buying by funds tracking the Nasdaq-100.
Warner Bros Discovery will be removed from the Nasdaq-100 and other indexes after its merger with Paramount Skydance completes on Oct 6.
downward pressure as funds sell the stock
Index removals cause passive fund outflows and can depress the share price.
Market effects
Biotech sector may see modest inflows as a high‑growth name joins a major index.
U.S. equity markets could see slight uplift in the Nasdaq-100 weighting.
Global index trackers will adjust holdings, affecting international fund flows.
Counterpoint
If the market has already priced Moderna's rally, the index addition may be a buy‑the‑rumor, not a catalyst.
Key entities
- companyModerna, Inc.
Biotech firm joining the Nasdaq-100.
- companyWarner Bros Discovery, Inc.
Media company being removed from the Nasdaq-100 after its merger.



